Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea

James Q. Del Rosso, Guy F. Webster, Mark Jackson, Marta Rendon, Phoebe Rich, Helen Torok, Mark Bradshaw

Research output: Contribution to journalArticle

162 Scopus citations

Fingerprint Dive into the research topics of 'Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea'. Together they form a unique fingerprint.

Medicine & Life Sciences